These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Trial experiences with the oral antidiabetic agent BZ-55; its use in 13 diabetics over a six month period. KERLAN M J Tn State Med Assoc; 1957 Feb; 50(2):46-8. PubMed ID: 13399061 [No Abstract] [Full Text] [Related]
23. [Clinical contribution to the study of antidiabetic effect of NI-sulfamilyl-N2-n-Butyl carbamide]. LAURIA D; NICOLETTI MN; ASCIONE A Riforma Med; 1957 Jun; 71(25):697-8. PubMed ID: 13454517 [No Abstract] [Full Text] [Related]
24. [Blood protein values and oral antidiabetic drugs; with a contribution to the statistical evaluation of median value differences reported without dispersion parameter]. KUHNE P; SCHULTZ GW Arztl Wochensch; 1957 Feb; 12(5):112-5. PubMed ID: 13402613 [No Abstract] [Full Text] [Related]
26. [Essay of a new sulfonamide (BZ55) in diabetes mellitus]. KODEJSZKO E; OKNINSKI W Pol Tyg Lek (Wars); 1956 Nov; 11(47):2008-10. PubMed ID: 13419682 [No Abstract] [Full Text] [Related]
27. [Results of the treatment of diabetes with new sulfonamide-urea preparations]. PUKHLEV A; TIKHOLOV K Suvr Med (Sofiia); 1957; 8(1):21-33. PubMed ID: 13455446 [No Abstract] [Full Text] [Related]
29. [Optic nerve disorders during peroral treatment of diabetes]. PURTSCHER E Wien Klin Wochenschr; 1957 May; 69(19):340. PubMed ID: 13456467 [No Abstract] [Full Text] [Related]
30. [New treatment of diabetes]. CASANOVA P Mars Med; 1957; 94(5):351-6. PubMed ID: 13440197 [No Abstract] [Full Text] [Related]
31. [New treatment of diabetes by sulfamido-carbamides]. ZEGARRA ARAUJO N An Fac Med Lima; 1957; 40(1):226-31. PubMed ID: 13444685 [No Abstract] [Full Text] [Related]
33. Clinical experience with a new oral hypoglycaemic drug. MUKHERJEE SK; DE UN; MUKERJI B J Indian Med Assoc; 1957 Jun; 28(11):466-8. PubMed ID: 13449331 [No Abstract] [Full Text] [Related]
34. [Clinical experiences with a new hypoglycemic sulfonamide derivative]. TISZAI A; SZUCS Z Orv Hetil; 1957 May; 98(21):546-9. PubMed ID: 13452524 [No Abstract] [Full Text] [Related]
35. [Oral therapy of diabetes mellitus]. LENGYEL L Orv Hetil; 1957 May; 98(21):550-3. PubMed ID: 13452525 [No Abstract] [Full Text] [Related]
37. [Preliminary study on the use of a new hypoglycemic drug, invenol, by oral route]. ROJAS F; BRAILOSKY D; SAAVEDRA J; DOONER H; PEIRANO P; ROMERO M Rev Med Chil; 1956 Aug; 84(8):408-11. PubMed ID: 13408725 [No Abstract] [Full Text] [Related]
38. [Oral therapy of diabetes with sulfanyl urea derivatives]. OTTO H Riforma Med; 1957 May; 71(18):489-93. PubMed ID: 13442483 [No Abstract] [Full Text] [Related]
39. [Hypoglycemic sulfonamides; their application to the treatment of diabetes mellitus]. CAMERINI-DAVALOS R; MOINAT P; ROOT HF Rev Med Suisse Romande; 1957 Mar; 77(3):144-62. PubMed ID: 13432458 [No Abstract] [Full Text] [Related]
40. [Changes in glycemia induced by sulfanil-n-butyl urea treatment of diabetes]. FEDELI S; MAGGI G Arch Sci Med (Torino); 1957 May; 103(5):368-75. PubMed ID: 13445445 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]